CD8A and neoplasm: Summarily, immunosuppressive state and metabolism-related pathway activation co-existed with high expression of Siglec-15, and patients with CD8L + S15H had the worst prognosis and higher TAMs infiltration, which indicated that Siglec-15 may impact tumor progression mainly when CD8+ T cell infiltration was low.